Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nationwide Outbreak of Candida auris Infections Driven by COVID-19 Hospitalizations, Israel, 2021-2022.
Biran R, Cohen R, Finn T, Brosh-Nissimov T, Rahav G, Yahav D, Amit S, Shachor-Meyouhas Y, Atamna A, Bishara J, Ashkenazi-Hoffnung L, Ben Zvi H, Hershman-Sarafov M, Maayan S, Maor Y, Schwartz O, Zimhony O, Lellouche J, Elbaz M, Burdelova E, Mizrahi N, Novikov A, Henig O, Ben-Ami R. Biran R, et al. Among authors: brosh nissimov t. Emerg Infect Dis. 2023 Jul;29(7):1297-1301. doi: 10.3201/eid2907.221888. Emerg Infect Dis. 2023. PMID: 37347492 Free PMC article. Review.
Testis sparing management of tuberculous epididymitis - Case report.
Hen E, Raz O, Brosh-Nissimov T, Maaravi N, Cooper A, Golomb D. Hen E, et al. Among authors: brosh nissimov t. Urol Case Rep. 2023 Mar 31;48:102390. doi: 10.1016/j.eucr.2023.102390. eCollection 2023 May. Urol Case Rep. 2023. PMID: 37089198 Free PMC article.
Dynamics of Invasive Pneumococcal Disease in Israel in Children and Adults in the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Era: A Nationwide Prospective Surveillance.
Ben-Shimol S, Regev-Yochay G, Givon-Lavi N, van der Beek BA, Brosh-Nissimov T, Peretz A, Megged O, Dagan R; Israeli Pediatric Bacteremia and Meningitis Group (IPBMG); Israeli Adult Invasive Pneumococcal Disease (IAIPD) Group. Ben-Shimol S, et al. Clin Infect Dis. 2022 May 3;74(9):1639-1649. doi: 10.1093/cid/ciab645. Clin Infect Dis. 2022. PMID: 34293091
A Randomized Controlled Study Assessing Convalescent Immunoglobulins vs Convalescent Plasma for Hospitalized Patients With Coronavirus 2019.
Maor Y, Shinar E, Izak M, Rahav G, Brosh-Nissimov T, Kessler A, Rahimi-Levene N, Benin-Goren O, Cohen D, Zohar I, Alagem N, Castro S, Zimhony O. Maor Y, et al. Among authors: brosh nissimov t. Clin Infect Dis. 2023 Oct 5;77(7):964-971. doi: 10.1093/cid/ciad305. Clin Infect Dis. 2023. PMID: 37220751 Free PMC article. Clinical Trial.
An international multicenter study comparing COVID-19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximab.
Shafat T, Grupel D, Porges T, Abuhasira R, Belkin A, Deri O, Oster Y, Zahran S, Horwitz E, Horowitz NA, Khatib H, Batista MV, Cortez AC, Brosh-Nissimov T, Segman Y, Ishay L, Cohen R, Atamna A, Spallone A, Chemaly RF, Ramos-Ramos JC, Chowers M, Rogozin E, Oren NC, Keske Ş, Barchad OW, Nesher L; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV). Shafat T, et al. Among authors: brosh nissimov t. Cancer Med. 2024 Feb;13(3):e6997. doi: 10.1002/cam4.6997. Cancer Med. 2024. PMID: 38400683 Free PMC article.
Clinical impact of the accelerate PhenoTest® BC system on patients with gram-negative bacteremia and high risk of antimicrobial resistance: a prospective before-after implementation study.
Brosh-Nissimov T, Tzur A, Grupel D, Cahan A, Ma'aravi N, Heled-Akiva M, Jawamis H, Leskes H, Barenboim E, Sorek N. Brosh-Nissimov T, et al. Ann Clin Microbiol Antimicrob. 2023 Jul 29;22(1):62. doi: 10.1186/s12941-023-00619-6. Ann Clin Microbiol Antimicrob. 2023. PMID: 37516885 Free PMC article.
59 results